IP Library Granted Patent US 7,223,834
Granted Patent B2
US 7,223,834 · App. 09/975,813 · Granted May 29, 2007

Assays and peptide substrate for determining aggrecan degrading metallo protease activity

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,223,834
App. No.
09/975,813
Granted
May 29, 2007
Kind
B2
Abstract

This invention is directed to assays to determine the presence or absence of proteins that exhibit aggrecanase or ADMP activity. This invention also relates to peptides that acts as a substrates for ADMPs, their use in various assays to determine the presence or absence of ADMP activity, and their use as inhibitors of ADMP activity.

Claims (24)

1. An isolated aggrecan peptide fragment consisting of amino acids 1–40 of SEQ ID NO:1, wherein said fragment is capable of functioning as a substrate for an aggrecan degrading metallo protease (ADMP).

2. An isolated aggrecan peptide fragment consisting of amino acids 1–40 of SEQ ID NO:2, wherein said fragment is capable of functioning as a substrate for an ADMP.

3. An isolated aggrecan peptide fragment consisting of amino acids 1–40 of SEQ ID NO:3, wherein said fragment is capable of functioning as a substrate for an ADMP.

4. A peptide of claims 1 , 2 , or 3 wherein the peptide further comprises a linking moiety.

5. A peptide of claim 4 wherein the linking-moiety is biotinylated or a biotinylated lysine.

6. A peptide of claim 4 wherein the linking-moiety comprises a chromophore.

7. A peptide of claim 4 wherein the linking moiety is a C-terminal linking-moiety.

8. A peptide of claim 4 wherein the linking moiety is a C-terminal biotinylated lysine.

9. A peptide of claim 4 wherein the linking moiety is an N-terminal linking-moiety.

10. A peptide of claim 4 wherein the linking moiety is an N-terminal biotinylated lysine.

11. An isolated proteolytic cleavage product, of the isolated peptide fragment of claim 1 , 2 , or 3 , consisting of the amino acids from the N-terminus through P1 of the ADMP-susceptible cleavage bond, wherein said product functions as an indicator of ADMP activity.

12. An isolated proteolytic cleavage product, of the isolated peptide fragment of claim 1 , 2 , or 3 , consisting the amino acids from P1′ of the ADMP-susceptible cleavage bond through the C-terminus, wherein said product functions as an indicator of ADMP activity.

13. A proteolytic cleavage product of claim 11 wherein the peptide is biotinylated.

14. A proteolytic cleavage product peptide of claim 11 wherein the peptide further comprises an N-terminal linking-moiety.

15. A proteolytic cleavage product peptide of claim 12 wherein the peptide further comprises a C-terminal linking-moiety.

16. A proteolytic cleavage product peptide of claim 14 wherein the linking-moiety is a biotinylated lysine.

17. A proteolytic cleavage product peptide of claim 15 wherein the linking-moiety is a biotinylated lysine.

18. A proteolytic cleavage product peptide of claim 14 wherein the linking-moiety comprises a chromophore.

19. A proteolytic cleavage product peptide of claim 15 wherein the linking-moiety comprises a chromophore.

20. An isolated, C-terminal biotinylated, aggrecan peptide fragment comprising SEQ ID NO:5.

21. An isolated, N-terminal biotinylated, aggrecan peptide fragment comprising SEQ ID NO:6.

22. A peptide of claim 1 , or 2 wherein the P1 ammo acid residue, Glu, of the ADMP-sensitive Glu 373 -Ala 374 bond, which corresponds to the bond between positions 20 and 21 of SEQ ID NO: 1 and SEQ ID NO: 2, is esterified.

23. A peptide of claim 1 , or 2 wherein the P1 ammo acid residue, Glu, of the ADMP-sensitive G 373 -Ala 374 bond, which corresponds to the bond between positions 20 and 21 of SEQ ID NO: 1 and SEQ ID NO: 2, is replaced with a Gln ammo acid residue.

24. A proteolytic cleavage product of claim 12 wherein the product is biotinylated.